The Centre for Biopharmaceutical Innovation combines The University of Queensland research and development with manufacturing expertise and capabilities of the industry partners. CBI conducts industry-driven research across three themes: discovery of new biopharmaceuticals and diagnostic agents; development of mammalian cells as factories for recombinant protein production; and advanced manufacturing of biopharmaceuticals. The CBI is located within the Australian institute for Bioengineering and Nanotechnology and collaborates with the co-located National Biologics Facility.

Website

http://www.arccbi.org/

Organisation type

• Australian Research Centre Industrial Transformation Research Hubs - Headquarters
• University Research Centre

Number of research staff

Up to 20 research staff

Address

Australian Institute for Bioengineering and Nanotechnology, Bldg 75, University of Queensland, College Road, St Lucia QLD 4072

Strengths and capabilities

• Diagnostic agents
• Biopharmaceuticals
• Advanced manufacturing
• Therapeutic protein development
• Antibody discovery

Facilities and major equipment

• Large-scale Physical Containment Class 2 (PC2) laboratory
• Suite of protein-analytical equipment
• Mammalian cell culture laboratory
• Bioreactors
• Downstream purification laboratory
• Antibody phage display laboratory
• Cell line development suite

Lead researcher

• Prof Trent Munro—Director National Biologics Facility, Program Director Vaccine Rapid Response pipeline - UQ Team working on a vaccine candidate for COVID-19
• Dr Esteban Marcellin Saldana—Metabolic pathway engineering for hyaluronic acid production, co-author in Grunwald P, 2016, Handbook of carbohydrate-modifying biocatalysts
• Prof. Paul Young—Research team leader for the UQ COVID-19 vaccine

Key science sectors

More information about the sectors this centre is involved in:

• Advanced manufacturing
• Biotechnology
• Engineering
• Health and medical